The independent source for health policy research, polling, and news.
61 - 80 of 97 Results
A medical billing specialist investigated her husband’s ER bill. Her sleuthing took over a year but knocked thousands of dollars off the hospital’s charges — and provides a playbook for other consumers.
A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.†The agency has received more than 100 reports of bad reactions among people who consumed it.
The Affordable Care Act required that health insurers provide many medical screenings and prevention services at no out-of-pocket cost to health plan members. But insurers and employers may consider adding cost sharing for preventive services now that a federal court ruled the ACA’s mandate is unconstitutional.
Abortion access is shaping races for legal office across the country, from local district attorneys to attorneys general. But it’s also highlighting the boundaries of their offices.
When Roe v. Wade was overturned, Wisconsin banned nearly all abortions. To preserve access, now more than a dozen providers are traveling across the border into Illinois to treat patients. This partnership between Planned Parenthood organizations could be a model as dozens of abortion clinics close across the U.S.
Spurred on by opposition to pandemic-related health mandates, a coalition of religious liberty groups, conservative think tanks, and Republican state attorneys general has filed a cascade of litigation seeking to rein in the powers of public health authorities.
Constraints imposed by the Special Supplemental Nutrition Assistance Program for Women, Infants, and Children, known as WIC, that prevent recipients from using benefits to buy formula across state lines weigh on families as the nationwide formula shortage drags on.
People talk about the sacrifices they made when health care forced them into debt.
A year ago, the Centers for Disease Control and Prevention awarded states and local health departments $2.25 billion to help people of color and other populations at higher risk from covid. But a KHN review shows public health agencies across the country have been slow to spend it.
Georgia may soon join a growing list of states decriminalizing the use of fentanyl testing strips. Bans of the strips — on the books in about half of states, experts say — stem from laws criminalizing drug paraphernalia adopted decades ago. But the testing devices are now recommended to help prevent overdose deaths.
Loan closets are playing an important role as supply chain issues and the rising price of aluminum have led to shortages in medical equipment such as wheelchairs, walkers, crutches, and knee scooters.
The Biden administration is getting rid of several policies implemented by Trump-era appointees that restricted enrollment. Federal officials now say states can no longer charge premiums to low-income residents enrolled in Medicaid and have ruled out work requirements.
A hospital in Wisconsin sued to keep seven employees from taking jobs with a competitor. A health system in South Dakota is offering nurses $40,000 signing bonuses. Facilities with fewer resources are finding it difficult or impossible to compete for health care workers.
Cities and nonprofits across the country are building communities of tiny homes to safely house people amid covid and cold winters. Proponents say tiny homes give people dignity and privacy, but some advocates for homeless people say they don't go far enough.
A KHN reporter had written for years about the people left behind by the absurdly complex and expensive U.S. health care system. Then he found himself navigating that maze as he tried to get his insulin prescription filled.
Hospitals and doctors are facing more demands for ivermectin as a covid-19 treatment, despite a lack of proof it works. In some Republican-dominated states, pushing for ivermectin interventions has become a conservative rallying cry.
Pharmacy benefit managers have curtailed in-person audits of pharmacy claims during the pandemic, switching to virtual audits done by computer. That has markedly increased the number of claims they can review — and the chances for payment denials — squeezing pharmacies and bringing in more cash for the benefit companies.
In an ongoing effort to control prescription drug costs, states are targeting the companies that mediate deals among drug manufacturers, health insurers and pharmacies. The pharmacy benefit managers say they negotiate lower prices for patients, yet the nitty-gritty occurs largely behind a curtain that lawmakers are trying to pull back.
Pandemic lockdowns exacerbated long-standing economic pressures on pharmacies — and forced many owner-operated shops to evolve or risk closing their doors.
With schools opening up classrooms, millions of young athletes are also getting out on fields and courts. But pandemic precautions and delays are spurring conflicts among parents, coaches and doctors.
© 2026 Â鶹ŮÓÅ